A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance
Authors:
- 17 October 2006
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (42) , 15523-15528
Abstract
Hemiasterlin is a potent antimitotic peptide that interferes with microtubule dynamics at picomolar concentrations in cell culture. The molecule largely eludes P glycoprotein-mediated drug efflux, and an analog is currently being evaluated in clinical trials as cancer chemotherapy. From a nonclonal genetic screen in Caenorhabditis elegans we isolated eight independent mutants resistant to a synthetic hemiasterlin analog. In one recessive mutant, phb-2(ad2154), a point mutation in prohibitin 2 (E130K) protects worms from drug-induced injury. Data indicate that direct binding of hemiasterlin to prohibitin 2 is unlikely. In fact, C. elegans phb-2(ad2154) was also found to be resistant to numerous other drugs that bind tubulin and to camptothecin, yet this mutant was sensitive to nocodazole and phalloidin. Thus, prohibitin 2 is implicated in a previously uncharacterized pathway of multidrug resistance.Keywords
This publication has 24 references indexed in Scilit:
- Silencing a prohibitin alters plant development and senescenceThe Plant Journal, 2005
- TaltobulinDrugs of the Future, 2005
- Prohibitin Induces the Transcriptional Activity of p53 and Is Exported from the Nucleus upon Apoptotic SignalingJournal of Biological Chemistry, 2003
- Synthesis and Antimitotic/Cytotoxic Activity of Hemiasterlin AnaloguesJournal of Natural Products, 2002
- Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysisProteomics, 2002
- Prohibitins act as a membrane‐bound chaperone for the stabilization of mitochondrial proteinsThe EMBO Journal, 2000
- Prohibitin, an antiproliferative protein, is localized to mitochondriaFEBS Letters, 1995
- Chapter 19 DNA Transformation1995
- Prohibition gene is overexpressed but not mutated in rat bladder carcinomas and cell linesCancer Letters, 1994
- A complementation analysis of the restriction and modification of DNA in Escherichia coliJournal of Molecular Biology, 1969